Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Citroma

Last content change checked dailysee data sync status

Active ingredient
Magnesium Citrate 1.745 g/29.6 mL
Other brand names
Drug classes
Calculi Dissolution Agent, Osmotic Laxative
Dosage form
Liquid
Route
Oral
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2018
Label revision date
February 23, 2026
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Magnesium Citrate 1.745 g/29.6 mL
Other brand names
Drug classes
Calculi Dissolution Agent, Osmotic Laxative
Dosage form
Liquid
Route
Oral
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2018
Label revision date
February 23, 2026
Manufacturer
Better Living Brands, LLC
Registration number
M007
NDC root
21130-165
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info
Packaging & NDC Codes

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Magnesium Citrate is an oral solution that acts as a saline laxative, designed to help relieve occasional constipation (irregularity). It typically works by drawing water into the intestines, which helps to stimulate a bowel movement within 30 minutes to 6 hours after taking it. This product is cherry-flavored and is available in a 10 FL OZ (296 mL) bottle.

If you're experiencing occasional constipation, Magnesium Citrate may provide the relief you need in a gentle and effective manner. It's important to follow the recommended guidelines for use to ensure safety and effectiveness.

Uses

If you're experiencing occasional constipation, this medication can help provide relief. It works by stimulating your bowels, typically resulting in a bowel movement within 30 minutes to 6 hours after taking it. This can be particularly useful if you're feeling irregular and need a gentle solution to get things moving again.

Dosage and Administration

Before you take your medication, make sure to shake the bottle well. When you're ready to take your dose, drink a full glass (8 ounces) of liquid along with it. You can take your medication either as a single dose each day or split it into smaller doses throughout the day.

For adults and children aged 12 and older, the recommended dose is between 6.5 to 10 fluid ounces, but you should not exceed 10 fluid ounces in a 24-hour period. If your child is between 6 and 12 years old, they should take between 3 to 7 fluid ounces, with a maximum of 7 fluid ounces in a day. For children aged 2 to under 6 years, the dose is 2 to 3 fluid ounces, not exceeding 3 fluid ounces in 24 hours. If your child is under 2 years old, please consult a doctor for guidance on the appropriate dosage.

What to Avoid

It's important to be aware of certain situations where you should stop using this medication and consult your doctor. If you experience rectal bleeding or if you do not have a bowel movement after using it, these could be signs of a serious condition that requires medical attention.

Currently, there are no specific contraindications, controlled substance classifications, or noted risks of abuse, misuse, or dependence associated with this medication. However, always prioritize your health and safety by following the guidance provided.

Side Effects

If you experience rectal bleeding or do not have a bowel movement after using this medication, it is important to stop using it and consult your doctor. These symptoms could indicate a serious condition that requires medical attention. Always prioritize your health and seek guidance if you have any concerns.

Warnings and Precautions

It's important to be aware of certain warnings and precautions when using this product. Before you start, consult your doctor if you have kidney disease, are on a magnesium or sodium-restricted diet, or if you experience abdominal pain, nausea, or vomiting. Additionally, if you notice a sudden change in your bowel habits that lasts for two weeks or have been using a laxative for more than a week, it's best to seek medical advice.

In case of an overdose, seek emergency medical help or contact a Poison Control Center immediately. You should also stop using the product and call your doctor if you experience rectal bleeding or do not have a bowel movement after use, as these could indicate a more serious health issue.

Overdose

It appears that there is no specific information available regarding overdosage for this medication. However, it's important to be aware of the general signs of an overdose, which can include symptoms like extreme drowsiness, confusion, or difficulty breathing. If you suspect an overdose, it is crucial to seek immediate medical help.

In case of an emergency, call your local emergency number or go to the nearest hospital. Always keep medications out of reach of children and follow the prescribed dosage to prevent any potential risks. If you have any concerns or questions about your medication, don’t hesitate to reach out to your healthcare provider for guidance.

Pregnancy Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using this medication. They can provide guidance on whether it’s safe for you and your baby. Always prioritize your health and the health of your child by seeking expert advice.

Lactation Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using any medication. This ensures that you understand any potential risks and can make informed decisions about your health and the health of your baby. Always prioritize open communication with your doctor regarding your breastfeeding journey.

Pediatric Use

When giving this medication to children, it's important to follow specific guidelines based on their age. For children aged 12 years and older, the maximum amount you can give in a 24-hour period is 10 fluid ounces, with a typical range of 6.5 to 10 fluid ounces. For those between 6 and 12 years old, the limit is 7 fluid ounces, while children aged 2 to under 6 years should receive no more than 3 fluid ounces in a day.

If your child is under 2 years old, it's essential to consult a doctor before administering this medication. Always ensure you adhere to these dosage recommendations to keep your child safe and healthy.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult, it’s important to consult with a healthcare provider before starting the medication. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that your medication dosage may need to be adjusted. Regular monitoring of your kidney function tests is essential to ensure your safety and the effectiveness of your treatment. If your creatinine clearance (a measure of how well your kidneys filter waste) is reduced, you might require a lower dose of your medication. Additionally, if you have severe renal impairment, special considerations will be necessary to manage your treatment effectively. Always consult your healthcare provider for personalized advice based on your kidney health.

Hepatic Impairment

If you have liver problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or precautions related to your condition. This means that there are no tailored recommendations for how the medication may affect you differently due to your liver health.

Always consult your healthcare provider for personalized advice and to ensure that any treatment plan is safe and effective for your specific situation. They can help determine the best approach based on your liver function and overall health.

Drug Interactions

It's important to be aware that certain medications can interact with each other, which may affect how well they work. For example, if you are taking laxatives like magnesium citrate, it's recommended to take them at least 2 hours before or after other medications. This helps ensure that the laxative does not interfere with the effectiveness of your other drugs.

Always discuss any medications you are taking with your healthcare provider. They can help you understand potential interactions and ensure that your treatment plan is safe and effective.

Storage and Handling

To ensure the best performance and safety of your product, store it at temperatures between 46° and 86°F (8° and 30°C). This temperature range helps maintain the integrity of the device.

When handling the product, be sure to do so with clean hands and in a clean environment to avoid contamination. Always follow any specific disposal instructions provided to ensure safe and responsible disposal of any components.

Additional Information

No further information is available.

FAQ

What is Magnesium Citrate?

Magnesium Citrate is an oral saline laxative solution used for the relief of occasional constipation. It comes in a cherry flavor and is saccharin-free.

How does Magnesium Citrate work?

It generally produces a bowel movement within 1/2 to 6 hours after ingestion.

What are the recommended dosages for adults and children?

Adults and children 12 years and over can take 6.5 to 10 fl oz, while children 6 to under 12 years can take 3 to 7 fl oz. For children 2 to under 6 years, the dosage is 2 to 3 fl oz.

Are there any contraindications for using Magnesium Citrate?

No specific contraindications are mentioned, but you should stop use and consult a doctor if you experience rectal bleeding or failure to have a bowel movement after use.

What precautions should I take before using Magnesium Citrate?

Consult a doctor if you have kidney disease, a magnesium or sodium restricted diet, abdominal pain, nausea, or a sudden change in bowel habits that persists for 2 weeks.

Can I use Magnesium Citrate if I am pregnant or breastfeeding?

If you are pregnant or breastfeeding, you should ask a healthcare professional before using Magnesium Citrate.

What should I do in case of an overdose?

In case of overdose, seek medical help or contact a Poison Control Center immediately.

How should I store Magnesium Citrate?

Store Magnesium Citrate at temperatures between 46° and 86°F (8° and 30°C).

Packaging Info

Below are the non-prescription pack sizes of Citroma (magnesium citrate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Citroma.
Details

Drug Information (PDF)

This file contains official product information for Citroma, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the relief of occasional constipation (irregularity). It generally produces a bowel movement within 1/2 to 6 hours of administration.

Limitations of Use: There are no known teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The medication should be shaken well before use. It is recommended that patients drink a full glass (8 ounces) of liquid with each dose. The medication may be administered as a single daily dose or divided into multiple doses throughout the day.

For adults and children aged 12 years and older, the dosage ranges from 6.5 to 10 fluid ounces, with a maximum limit of 10 fluid ounces within a 24-hour period.

For children aged 6 to under 12 years, the recommended dosage is between 3 to 7 fluid ounces, not exceeding 7 fluid ounces in a 24-hour period.

For children aged 2 to under 6 years, the dosage should be between 2 to 3 fluid ounces, with a maximum of 3 fluid ounces in a 24-hour period.

For children under 2 years of age, it is advised to consult a physician for appropriate dosing recommendations.

Contraindications

Use is contraindicated in patients experiencing rectal bleeding or failure to have a bowel movement after use, as these symptoms may indicate a serious underlying condition. In such cases, it is essential to discontinue use and consult a healthcare professional.

Warnings and Precautions

Patients should be advised of the following warnings and precautions associated with the use of this product.

Warnings This product is contraindicated in certain populations and should be used with caution.

General Precautions Healthcare professionals should counsel patients to consult a physician prior to use if they have any of the following conditions:

  • Kidney disease

  • A magnesium or sodium-restricted diet

  • Abdominal pain, nausea, or vomiting

  • A sudden change in bowel habits that persists for more than two weeks

  • A history of laxative use for longer than one week

Emergency Medical Help In the event of an overdose, patients should seek immediate medical assistance or contact a Poison Control Center.

Discontinuation and Consultation Patients are advised to discontinue use and consult a healthcare provider if they experience rectal bleeding or fail to have a bowel movement after use, as these symptoms may indicate a serious underlying condition.

Side Effects

Patients should discontinue use and consult a healthcare professional if they experience rectal bleeding or failure to have a bowel movement after use, as these symptoms may indicate a serious underlying condition.

Drug Interactions

Laxatives, particularly magnesium citrate, may influence the efficacy of concurrent medications. It is recommended that this product be administered at least 2 hours before or after the intake of other drugs to minimize potential interactions.

Currently, there is no available information regarding other drug interactions or interactions with laboratory tests. Therefore, healthcare professionals should remain vigilant and monitor for any unexpected effects when magnesium citrate is used in conjunction with other medications.

Packaging & NDC

Below are the non-prescription pack sizes of Citroma (magnesium citrate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Citroma.
Details

Pediatric Use

Pediatric patients aged 12 years and older may receive a dosage of 6.5 to 10 fl oz, with a maximum limit of 10 fl oz in a 24-hour period. For children aged 6 to under 12 years, the recommended dosage ranges from 3 to 7 fl oz, not exceeding 7 fl oz in 24 hours. In children aged 2 to under 6 years, the dosage is 2 to 3 fl oz, with a maximum of 3 fl oz in 24 hours. For infants and children under 2 years of age, it is advised to consult a doctor before administration.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Renal impairment may necessitate dosage adjustments for patients with reduced kidney function. It is essential to monitor renal function tests regularly in these patients to ensure appropriate management. Specifically, patients with reduced creatinine clearance may require a reduced dose to avoid potential toxicity. Additionally, special considerations should be taken for patients with severe renal impairment to ensure their safety and the efficacy of treatment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

There is currently no specific information available regarding overdosage for this medication. Healthcare professionals are advised to monitor patients closely for any signs of adverse effects or symptoms that may arise from excessive dosing.

In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Patients should be evaluated for potential complications, and appropriate interventions should be implemented based on the clinical presentation.

For further guidance, healthcare professionals may refer to established protocols for managing drug overdosage or consult a poison control center.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center in the event of an overdose. It is important for patients to be aware of the signs that warrant discontinuation of the product; they should stop use and consult a doctor if they experience rectal bleeding or fail to have a bowel movement after use, as these symptoms may indicate a serious condition.

Patients should be encouraged to consult with their healthcare provider prior to using this product if they have any of the following conditions: kidney disease, a magnesium or sodium restricted diet, abdominal pain, nausea, or vomiting. Additionally, patients should be informed that a sudden change in bowel habits persisting for more than two weeks or the use of a laxative for longer than one week also necessitates a discussion with their doctor.

Furthermore, patients should be instructed to consult a doctor or pharmacist before using this product if they are currently taking any other medications. It is essential to inform patients that they should take this product at least two hours before or after taking other drugs, as laxatives may influence the effectiveness of other medications.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at temperatures ranging from 46° to 86°F (8° to 30°C) to maintain its efficacy and safety. Proper storage conditions must be adhered to, ensuring that the product is kept within the specified temperature range to prevent degradation.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Citroma, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Citroma, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.